AnnJi Pharmaceutical
Taipei
About AnnJi Pharmaceutical
AnnJi Pharmaceutical is a clinical-stage drug development company that specializes in developing small molecules that address unmet medical needs in the areas of neurology, dermatology, and inflammatory disorders, including rare diseases such as idiopathic pulmonary fibrosis and Kennedy’s disease, and SBMA (Spinal and bulbar muscular atrophy). The focus of the company is on creating global collaborations and business partnerships in the late-stage product development and commercialization of pharmaceutical drugs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $21.1M
- Last round: Series Unknown (Jul 2023)
- Website: ajpharm.com
- Phone: +886 2 2365-5677
Industries & Categories
Biotechnology, Health Care, Medical, Neuroscience, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/annji-pharmaceutical-25724 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.